Johan van Hylckama Vlieg - 14 Jan 2022 Form 4 Insider Report for Kaleido Biosciences, Inc.

Role
Chief Scientific Officer
Signature
/s/ Johan van Hylckama Vlieg
Issuer symbol
N/A
Transactions as of
14 Jan 2022
Net transactions value
$0
Form type
4
Filing time
18 Jan 2022, 16:18:21 UTC
Previous filing
02 Sep 2021
Next filing
02 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Restricted Stock Units Award $0 +350,000 $0.000000 350,000 14 Jan 2022 Common Stock 350,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
F2 The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.